We would like to invite you to the next webinar hosted by Evidence Prime, which will take place on the 31st of May at 17:00 CEST!
Last time, in the Laser AI webinar series we were talking about recent developments and a roadmap for 2023. Today we would like to touch on the hot topic of AI and discover if ChatGPT is able to substitute Systematic Review tools and software. Is GPT-4 the only model we need?
Are you curious about the future of evidence synthesis and the role of language models like GPT-4? Join our Laser AI webinar as we explore the captivating topic: "Is Chat GPT going to replace Systematic Review Tools?"
The exponential growth of scientific literature has created a pressing need for efficient data extraction and evidence synthesis. Natural Language Processing (NLP) techniques, including large language models, have emerged as powerful tools to address this challenge by automating the processing, analysis, and summarization of scientific papers. In this webinar, we delve into the potential of Laser AI in evidence synthesis. We go beyond GPT-4 to discuss alternative approaches tailored to the unique requirements of extracting data from scientific publications.
Who Should Attend:
- Researchers and professionals in evidence synthesis
- NLP enthusiasts and researchers
- Data scientists and machine learning practitioners
- Professionals working with scientific literature
- Anyone interested in the future of Laser AI in evidence synthesis
During the presentation, we will explore why alternative approaches to ChatGPT should be used in evidence synthesis. Next, our team will discuss how Laser AI keeps your data safe, and we will give an update on the new milestone reached by Evidence Prime.
Don't miss out on this exciting opportunity to gain insights into the advancements in evidence synthesis and the potential of language models. Reserve your spot for the Laser AI webinar today!
Join us on Wednesday, May 31.
Speakers:
Co-founder and the CTO of Evidence Prime. He helps the brightest minds answer the most challenging questions in healthcare through his work in the area of artificial intelligence, especially in the context of systematic review automation.
Co-founder and the president of Evidence Prime. He focuses on enterprise, security and AI features of Evidence Prime software and manages the company operations.
